Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Equity Income Wisdomtree | DHS | 14. nov 2024 | 97.43 | -0.09 |
Equity Lifestyle Properties | ELS | 14. nov 2024 | 71.71 | -1.02 |
Equity Residential | EQR | 14. nov 2024 | 73.07 | -2.10 |
Equus Total Return | EQS | 14. nov 2024 | 1.31 | +0.59 |
EQV Ventures Acquisition | EQV | 14. nov 2024 | 9.93 | 0.00 |
Erasca | ERAS | 14. nov 2024 | 2.81 | -1.40 |
Erayak Power Solution Group A | RAYA | 14. nov 2024 | 1.11 | -9.02 |
Ericsson B ADR | ERIC | 14. nov 2024 | 8.00 | +0.13 |
Erie Indemnity A | ERIE | 14. nov 2024 | 406.11 | -1.09 |
Ermenegildo Zegna N.V. | ZGN | 14. nov 2024 | 7.45 | -2.61 |
Ero Copper | ERO | 14. nov 2024 | 15.43 | -1.15 |
ESAB | ESAB | 14. nov 2024 | 126.44 | -1.93 |
Escalade | ESCA | 14. nov 2024 | 14.46 | +0.14 |
Esco Technologies | ESE | 14. nov 2024 | 140.00 | -2.31 |
ESGL | ESGL | 14. nov 2024 | 1.87 | -0.46 |
ESH Acquisition | ESHA | 14. nov 2024 | 10.69 | +0.09 |
Eshallgo | EHGO | 14. nov 2024 | 3.95 | +0.77 |
Esperion Therapeutics | ESPR | 14. nov 2024 | 2.10 | -5.83 |
Espey Mfg & Electronics | ESP | 14. nov 2024 | 30.14 | -2.81 |
Esquire Financial | ESQ | 14. nov 2024 | 72.66 | -2.34 |
ESS Tech | GWH | 14. nov 2024 | 7.33 | -17.64 |
ESSA Bancorp | ESSA | 14. nov 2024 | 20.18 | +1.46 |
ESSA Pharma | EPIX | 14. nov 2024 | 1.76 | -0.57 |
Essent Group | ESNT | 14. nov 2024 | 55.66 | -2.14 |
Essential Properties Realty Trust | EPRT | 14. nov 2024 | 32.66 | -1.21 |
Essential Utilities | WTRG | 14. nov 2024 | 38.26 | -0.70 |
Essex Property Trust | ESS | 14. nov 2024 | 302.74 | -1.48 |
Establishment Labs | ESTA | 14. nov 2024 | 37.51 | -4.60 |
Estee Lauder Companies | EL | 14. nov 2024 | 64.83 | +3.13 |
Estrella Immunopharma | ESLA | 14. nov 2024 | 0.84 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.